Status: Not yet recruiting
The LUCENT Study - LUng Lesion Assessment Via BF-UCP190F for Central and Extended Nodal Targeting
The Olympus BF-UCP190F bronchoscope combines the reach of a thinner bronchoscope with the benefit of real-time ultrasound, enabling direct lesion visualization and sampling deeper into the lung. Following promising first-in-human data, the LUCENT study aims to evaluate the utility feasibility, effectiveness and safety of this device in a multicenter setting, generating real-world evidence to inform broader adoption in global markets.
Participants needed: 200
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Olympus Europe SE & Co. KGUpdated: Nov 28, 2025
Eligibility criteria
Willing and able to provide informed consent. [+7]
Concurrently participating in another competing clinical study. [+4]